| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |